Locating Therapeutic Vaccines in Nineteenth-Century History
Bibliographic Data
| ID | 4516094 |
|---|---|
| Authors | Christoph Gradmann (0000-0003-4835-7394, University of Oslo, corresponding author) |
| Year | 2008 |
| Volume | 21 |
| Issue | 2 |
| Pages | 145-160 |
| Publication date | 2008-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science in Context (JOURNAL) |
| Journal identifiers | ISSN: 0269-8897 • E-ISSN: 1474-0664 |
| Publisher | Cambridge University Press (CUP) (PUBLISHER) |
| DOI | 10.1017/s026988970800166x |
| PMID | 18831134 |
| OpenAlex | W2113078718 |
| Language | EN |
| Citations received | 12 |
| References cited | 25 |
ArgumentThis essay places some therapeutic vaccines, including particularly the diphtheria antitoxin, into their larger historical context of the late nineteenth century. As industrially produced drugs, these vaccines ought to be seen in connection with the structural changes in medicine and pharmacology at the time. Given the spread of industrial culture and technology into the field of medicine and pharmacology, therapeutic vaccines can be understood as boundary objects that required and facilitated communication between industrialists, medical researchers, public health officials, and clinicians. It was in particular in relation to evaluation and testing for efficacy in animal models that these medicines became a model for twentieth-century medicine. In addition, these medicines came into being as a parallel invention in two very distinct local cultures of research: the Institut Pasteur in Paris and the Institut für Infektionskrankheiten in Berlin. While their local cultural origins were plainly visible, the medicines played an important role in the alignment of the methods and objects that took place in bacteriology research in France and Germany in the 1890s. This article assesses the two locally specific regimes for control in France and in Imperial Germany. In France the Institut Pasteur, building on earlier successful vaccines, enjoyed freedom from scrutinizing control. The tight and elaborate system of control that evolved in Imperial Germany is portrayed as being reliant on experiences that were drawn from the dramatic events that surrounded the launching of a first example of so-called "bacteriological medicine," tuberculin, in 1890
Historical Medical Research and Treatments · History · Medical History and Innovations · Medicine
Un Remedio Global en El Río De La Plata
"Living versus Dead"
La producción de vacunas en el Instituto Bacteriológico del Departamento Nacional de Higiene
Robert Koch and the invention of the carrier state
Inventing with bacteriology
The symbolic economy of drugs
The animal model of human disease as a core concept of medical research
General Introduction
Dilemmas of a Vitalizing Vaccine Market
Der erste zu sein.“ [1] – Über den ersten Medizinnobelpreis für Emil von Behring im Jahr 1901
A Brave New Animal for a Brave New World
De Bombaim ao Rio de Janeiro
The Laboratory Revolution in Medicine
The Invisible Industrialist
The Values of Precision
Appropriation and commercialization of the Pasteur anthrax vaccine
Krankheit im Labor
Vaccination Policy Against Smallpox, 1835-1914
Institutional Ecology, `Translations' and Boundary Objects
Medical and Biological Constraints
On hybridizations, networks and new disciplines
The History of Smallpox Vaccination in Germany
The Theoretical Basis of Paul Ehrlich's Chemotherapy
Science as Receptor of Technology
Patentgesetzgebung und Chemisch-Pharmazeutische Industrie im Deutschen Kaiserreich, 1871-1918
The History of Science and the Sciences of Medicine
| Unique citing works | 12 |
|---|---|
| Citations per year | 0,75 |
| Citation span | 2010 - 2024 (15) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 10 |